What’s the difference between research peptides and pharmaceutical peptides?

A peptide sold “for research use only” is presented as a laboratory reagent, not an approved medicine for patients. An FDA-approved peptide drug is a specific finished product with reviewed evidence, manufacturing controls, labeling, and a defined clinical use. “Pharmaceutical grade” on a website is not itself an FDA approval category, and a familiar molecule name does not establish that two products are interchangeable.[1][2]

Compounded preparations form a separate category. They can meet particular medical needs, but FDA does not review each compounded drug for safety, effectiveness, and quality before it is marketed. They should not be described as approved generics simply because they contain, or claim to contain, a similar ingredient. Whether compounding a particular substance is permitted is a distinct regulatory question from whether it works.[2]

A purity percentage alone cannot answer whether a vial contains the correct amount, is sterile, is free of bacterial endotoxins, or remains stable during storage. Peptide impurities and aggregation can also matter for immune reactions. Clinical results from a verified trial product cannot automatically be assigned to an online reagent with an uncertain supply chain, even when both labels use the same peptide name.[3]